First-of-a-kind Patent Litigation: Biosimilars
Oleksandr S. Mamunya, Nataliya A. Dryuk
Over the past few decades, biologicdrugs have revolutionizedtreatment for many conditions, includingthose that had not respondedto other treatment. Biologic drugscontain active substances of biologicalorigin obtained through productionfrom biological source and onmany occasions can bring more targetedeffect than traditional chemicallyderived small-molecule drugs.No wonder that biological drugslead the charts of best-selling drugsin the world and their sales groweach year. However, while bringinggreat advantages for patients, biologicsare often expensive in termsof cost per dose…
The abstract/extract view of this article is free. Access to the full text of this article requires a subscription.
Please send subscription inquiries by:
Phone: +380 44 495-27-27
E-mail: subscribe@ujbl.info